Abdominal Adipose Tissue Linked to Musculoskeletal Pain
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- For women and men, abdominal adipose tissue is associated with chronic musculoskeletal pain, according to a study published online Sept. 10 in Regional Anesthesia & Pain Medicine.
Zemene Demelash Kifle, from the University of Tasmania Menzies Institute for Medical Research in Australia, and colleagues used data from the U.K. Biobank to describe the associations between magnetic resonance imaging (MRI)-derived abdominal adipose tissue and multisite widespread chronic musculoskeletal pain. Visceral adipose tissue and subcutaneous adipose tissue were quantified on abdominal MRI scans performed at two imaging visits. At corresponding visits, pain was assessed in the neck/shoulder, back, hip, knee, or "all over the body."
The study included 32,409 participants (50.8 percent women). The researchers found a dose-response association of visceral adipose tissue, subcutaneous adipose tissue, and their ratio with the number of chronic pain sites in both women (odds ratios [OR], 2.04, 1.60, and 1.60 per standard deviation, respectively) and men (OR, 1.34, 1.39, and 1.13, respectively) in multivariable analyses. In both sexes, higher levels of adipose tissue were also associated with increased odds of reporting chronic pain. In women versus men, the effect estimates of these adipose measures were relatively larger.
"Abdominal adipose tissue was associated with chronic musculoskeletal pain, suggesting that excessive and ectopic fat depositions may be involved in the pathogenesis of multisite and widespread chronic musculoskeletal pain," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.